drugset / Trial / NCT00441025
The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether the treatment of Alemtuzumab in combination with CHOP(cyclophosphamide,doxorubicin,vincristine and prednisolone) are effective as first line treatment in patients with peripheral T-cell lymphoma.
Timeline
- Start
- 2006-09
- Primary completion
- —
- Completion
- 2009-08
Outcome
Outcome not reported
Stopped: “a lack of a potential patient.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alemtuzumab | Monoclonal antibody | — | — |